Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
is an cancer drug candidate under clinical trial
which target the Beclin1 subunit of Vps34 complexes
KYA1797K was suggested to be used at 25 µM final concentration in vitro
10 μM) shows no effect on HBEC30KT and HCC44 cell lines due to the up-regulation of p21CDKN1A
SU5416 selectively inhibits VEGF-driven mitogenesis in a dose-dependent manner with IC50 of 0
p53 and MDM2 proteins-interaction-inhibitor dihydrochloride N-Desmethyl Imatinib is an cancer drug candidatep53 and MDM2 proteins interaction inhibitor chiral is an inhibitor of the interaction between p53 and MDM2 proteins. Product information CAS Number: 2070009 27 5 Molecular Weight: 807. 68 Formula: C40H51Cl4N5O4 Chemical Name: 2 {4 [(4S, 5R) 2 (4 tert butyl 2 ethoxyphenyl) 4, 5 bis(4 chlorophenyl) 4, 5 dimethyl 4, 5 dihydro 1H imidazole 1 carbonyl]piperazin 1 yl} 1 (morpholin 4 yl)ethan 1 one dihydrochloride Smiles: Cl. Cl.